Cord Blood Transplantation

Treatment For Adult Leukemia And Lymphoma Is Feasible

Published in Cancer Weekly, July 17th, 2001

A study by researchers at University Hospitals of Cleveland, Ohio, demonstrates that, in adults, umbilical-cord blood from unrelated donors is a feasible alternative source of stem cells for transplantation in leukemia and other blood disorders.

Ninety percent of patients in the study experienced reconstitution of blood cells (hematopoeisis) and the incidence of graft-versus-host disease was low despite genetic mismatching of donors and recipients. Further, 19 of the study's very high risk patients (26%) were alive and 18 patients disease-free 40 months after transplantation. The study appeared in the June 14, 2001, New England Journal of Medicine.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2001-07-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry